Possibilities of histological studies in non-uremic rabbit model of peritoneal dialysis

Journal of Animal and Veterinary Advances

Volumn 10, Issue 11, 2011, Pages 1414-1420

  Stojimirovic, Biljana ^a   Jovanovic, Natasa ^a   Lausevic, Zeljko ^a   Krstic, Slobodan ^a   Trbojevic Stankovic, Jasna ^b   Trpinac, Dusan ^c   Zunic Bozinovski, Snezana ^c  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Clinical Hospital Center Dr D Misovic   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Experimental model; Histological studies; Morphometric analysis; Peritoneal dialysis; Rabbit

Indexed keywords

EID: 80052081181     PISSN: 16805593     EISSN: 1993601X     Source Type: Journal    
DOI: 10.3923/javaa.2011.1414.1420     Document Type: Article

References (35)

1. Coles, G.A. and N. Topley, 2000. Long-term peritoneal membrane changes. Adv. Ren. Replace Ther., 7: 289-301.
2. Davies, S.J., L. Philipps, R.F. Naish and G.I. Russell, 2001. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J. Am. Soc. Nephrol., 12: 1046-1051.
3. De Vriese, A.S., R.G. Tilton, C.C. Stephan and N.H. Lameire, 2001. Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alterations of the peritoneal membrane. J. Am. Soc. Nephrol., 12: 1734-1741.
4. De Vriese, A.S., S. Mortier, M. Cornelissen, E. Palmans and N.J. Vanacker et al., 2002. The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure. Perit. Dial. Int., 22: 566-572.
5. Devuyst, O., 2001. Molecular mechanisms of peritoneal permeability-research in growth factors. Perit. Dial. Int., 21: S19-S23.
6. Di Paolo, N., G. Garosi, G. Petrini, L. Traversari and P. Rossi, 1995. Peritoneal dialysis solution biocompatibility testing in animals. Perit. Dial. Int., 15: S61-S69.
7. Di Paolo, N., G. Sacchi, M. De Mia, E. Gaggiotti and L. Capotondo et al., 1986. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron, 44: 204-211.
8. Flessner, M.F., J. Choi, H. Vanpelt, Z. He, K. Credit, J. Henegar and M. Hughson, 2006. Correlating structure with solute and water transport in a chronic model of peritoneal inflammation. Am. J. Physiol. Renal Physiol., 290: F232-F240.
9. Hekking, L.H.P., M. Zareie, B.A.J. Driesprong, D. Faict and A.G. Welten et al., 2001. Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solution. J. Am. Soc. Nephrol., 12: 2775-2786.
10. Honda, K., K. Nitta, S. Horita, W. Yumura and H. Nihei et al., 1999. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultrafiltration. Nephrol. Dial. Transplant., 14: 1541-1549.
11. Jorres A. and J. Witowski, 2005. Lessons from basic research for PD treatment. Perit. Dial. Int., 25: S35-S38.
12. Margetts, P.J., M. Kolb, L. Yu, C.M. Hoff and J. Gauldie, 2001a. A chronic inflammatory infusion model of peritoneal dialysis in rats. Perit. Dial. Int., 21: S368-S372.
13. Margetts, P.J., M. Kolb, L. Yu, C.M. Hoff, C.J. Holmes, D.C. Anthony and J. Gauldie, 2002. Inflammatory cytokines, angiogenesis and fibrosis in the rat peritoneum. Am. J. Pathol., 160: 2285-2294.
14. Margetts, P.J., M. Kolb, T. Galt C.M. Hoff, T.R. Shockley and J. Gauldie, 2001b. Gene transfer of transforming growth factor-β1 to the rat peritoneum: Effects on membrane function. J. Am. Soc. Nephrol., 12: 2029-2039.
15. Mortier, S., A.S. De Vriese, A. Leyssens, N.J. Vanacker and D. Faict et al., 2003. Antibiotic administration in an animal model of chronic peritoneal dialysate exposure. Perit. Dial. Int., 23: 331-338.
16. Mortier, S., N.H. Lamiere and A.S. De Vriese, 2005. Animal models in peritoneal dialysis research: A need for consensus. Perit. Dial. Int., 25: 16-24.
17. Musi, B., O. Carlsson, A. Rippe, A. Wieslander and B. Rippe, 1998. Effects of acidity, glucose degradation products and dialysis fluid buffer choice on peritoneal solute and fluid transport in rats. Perit. Dial. Int., 18: 303-310.
18. Nakayama, M., Y. Kawaguchi, K. Yamada, T. Hasegawa and K. Takazoe et al., 1997. Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int., 51: 182-186.
19. Peng, W.X., Q.Y. Guo, S.M. Liu, C.Z. Liu, B. Lindholm and T. Wang, 2000. Comparison of three chronic dialysis models. Adv. Perit. Dial., 16: 51-54.
20. Schambye, H.T., P. Flesner, R.B. Pedersen, M. Hardt-Madsen and J. Chemnitz et al., 1992. Bicarbonate versus lactate-based CAPD fluids: A biocompatibility study in rabbits. Perit. Dial. Int., 12: 281-286.
21. Smit, W., A. Pankova, D.G. Strujik and R.T. Krediet, 2005. The difference in causes of early and late ultrafiltration failure in peritoneal dialysis. Perit. Dial. Int., 25: S41-S45.
22. Stojimirovic, B., J. Trbojevic-Stankovic and D. Nesic, 2007. Animal models in peritoneal dialysis. Scand. J. Lab. Amm. Sci., 34: 283-289.
23. Stojimirovic, B.B., M.M. Obradovic, D.P. Trpinac, D.D. Milutinovic, D.I. Obradovic and V.B. Nesic, 2001. Mesothelial paracrystalline inclusions in continuous ambulatory peritoneal dialysis patients. Perit. Dial. Int., 21: S54-S57.
24. Topley, N., 2005. Animal models in peritoneal dialysis: More questions than answers. Perit. Dial. Int., 25: 33-34.
25. Trbojevic-Stankovic, J., Z. Milicevic, Z. Lausevic, N. Milicevic, M. Obradovic and B. Stojimirovic, 2007. Histomorphometric characteristics of peritoneal blood microvessels. Med. Pregl., 60: 58-61.
26. Wieczorowska-Tobis, K., K. Korybalska, A. Polubinska, M. Radkowski, A. Breborowicz and D.G. Oreopoulos, 1997. In vivo model to study the biocompatibility of peritoneal dialysis solutions. Int. J. Artif. Organs, 20: 673-677.
27. Wieczorowska-Tobis, K., R. Brelinska, J. Witowski, J. Passlick-Deetjen, T.P. Schaub, H. Schilling and A. Breborowicz, 2004. Evidence for less irritation to the peritoneal membrane in rats dialyzed with solutions low in glucose degradation products. Perit. Dial. Int., 24: 48-57.
28. Wieslander, A., T. Linden, B. Musi, O. Carlsson and R. Deppisch, 2000. Biological significance of reducing glucose degradation products in peritoneal dialysis fluids. Pent. Dial. Int., 20: S23-S27.
29. Williams, J.D., K.J. Craig, N. Topley, C.V. Ruhland and M. Fallon et al., 2002. Morphologic changes in the peritoneal membrane of patients with renal disease. J. Am. Soc. Nephrol., 13: 470-479.
30. Witowski, J. and A. Jorres, 2005. Effects of peritoneal dialysis solutions on the peritoneal membrane: Clinical consequences. Perit. Dial. Int., 25: S31-S34.
31. Witowski, J., K. Korybalska, J. Wisniewska, A. Breborowicz and G.M. Gahl et al, 2000. Effect of glucose degradation products on human peritoneal mesothelial cell function. J. Am. Soc. Nephrol., 11: 729-739.
32. Zareie, M., L.H.P. Hekking, A.G.A. Welten, B.A.J. Driesprong and I.L. Schadee-Eestermans et al., 2003. Contribution of lactate buffer, glucose and glucose degradation products to peritoneal injury in vivo. Nephrol. Dial. Transplant., 18: 2629-2637.
33. Zunic-Bozinovski, S., B. Stojimirovic, Z. Lausevic, S. Krstic, J. Trbojevic-Stankovic and N. Jovanovic, 2008. Modification of peritoneal dialysis model on rabbits: Pilot study. Srp. Arh. Celok. Lek., 136: 38-43.
34. Zweers, M.M., C.E. Douma, D.R. de Waart, A.B. van der Wardt, M.M. Ho-dac-Pannekeet, R.T. Krediet and D.G. Struijk, 1999. The standard peritoneal permeability analysis in the rabbit: A longitudinal model for peritoneal dialysis. Perit. Dial. Int., 19: 56-64.
35. Zweers, M.M., J. Splint, R.T. Krediet and D.G. Struijk, 2001. Ultrastructure of basement membranes of peritoneal capillaries in a chronic peritoneal infusion model in the rat. Nephrol. Dial. Transplant., 16: 651-654.